170 related articles for article (PubMed ID: 32735852)
41. Imaging and clinical features of colorectal liver metastases with macroscopic intrabiliary growth.
Zeng H; Shi G; Mai S; Liu H; Wu Z
Eur J Radiol; 2021 Apr; 137():109616. PubMed ID: 33676138
[TBL] [Abstract][Full Text] [Related]
42. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
[TBL] [Abstract][Full Text] [Related]
43. An Optimal Orthotopic Mouse Model for Human Colorectal Cancer Primary Tumor Growth and Spontaneous Metastasis.
Hite N; Klinger A; Hellmers L; Maresh GA; Miller PE; Zhang X; Li L; Margolin DA
Dis Colon Rectum; 2018 Jun; 61(6):698-705. PubMed ID: 29722728
[TBL] [Abstract][Full Text] [Related]
44. Colorectal cancer recurrence in the liver: detection by PET.
Yasuda S; Makuuchi Y; Sadahiro S; Mukai M; Tokunaga N; Tajima T; Shohtsu A
Tokai J Exp Clin Med; 1998 Oct; 23(4):167-71. PubMed ID: 10359505
[TBL] [Abstract][Full Text] [Related]
45. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
[TBL] [Abstract][Full Text] [Related]
46. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
[TBL] [Abstract][Full Text] [Related]
47. A comparison of diagnostic imaging modalities for colorectal liver metastases.
Bonanni L; de'Liguori Carino N; Deshpande R; Ammori BJ; Sherlock DJ; Valle JW; Tam E; O'Reilly DA
Eur J Surg Oncol; 2014 May; 40(5):545-550. PubMed ID: 24491289
[TBL] [Abstract][Full Text] [Related]
48. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases.
Zhang H; Li W; Hu F; Sun Y; Hu T; Tong T
Abdom Radiol (NY); 2019 Jan; 44(1):65-71. PubMed ID: 29967982
[TBL] [Abstract][Full Text] [Related]
49. MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study.
Milot L; Guindi M; Gallinger S; Moulton CA; Brock KK; Dawson LA; Haider MA
Radiology; 2010 Mar; 254(3):747-54. PubMed ID: 20123902
[TBL] [Abstract][Full Text] [Related]
50. Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastases.
Schulz A; Godt JC; Dormagen JB; Holtedahl JE; Bogsrud TV; Labori KJ; Kløw NE; Bach-Gansmo T
Eur J Radiol; 2015 Aug; 84(8):1424-1431. PubMed ID: 26044293
[TBL] [Abstract][Full Text] [Related]
51. Liver metastases of colorectal cancer: US, CT or MR?
Schima W; Kulinna C; Langenberger H; Ba-Ssalamah A
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S149-56. PubMed ID: 16361131
[TBL] [Abstract][Full Text] [Related]
52. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
53. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
54. Imaging strategies before beginning treatment of colorectal liver metastases.
Legou F; Chiaradia M; Baranes L; Pigneur F; Zegai B; Djabbari M; Calderaro J; Laurent A; Kobeiter H; Rahmouni A; Luciani A
Diagn Interv Imaging; 2014 May; 95(5):505-12. PubMed ID: 24794793
[TBL] [Abstract][Full Text] [Related]
55. [The value of radiotherapy for liver metastases].
Eble MJ; Gademann G; Wannenmacher M
Strahlenther Onkol; 1993 Aug; 169(8):459-68. PubMed ID: 7689254
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases.
Brunsell TH; Cengija V; Sveen A; Bjørnbeth BA; Røsok BI; Brudvik KW; Guren MG; Lothe RA; Abildgaard A; Nesbakken A
Eur J Surg Oncol; 2019 Dec; 45(12):2340-2346. PubMed ID: 31350075
[TBL] [Abstract][Full Text] [Related]
57. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
[TBL] [Abstract][Full Text] [Related]
58. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.
Heijmen L; ter Voert EE; Oyen WJ; Punt CJ; van Spronsen DJ; Heerschap A; de Geus-Oei LF; van Laarhoven HW
PLoS One; 2015; 10(4):e0120823. PubMed ID: 25831053
[TBL] [Abstract][Full Text] [Related]
59. Meeting the biologic challenge of colorectal metastases.
Wanebo HJ; LeGolvan M; Paty PB; Saha S; Zuber M; D'Angelica MI; Kemeny NE
Clin Exp Metastasis; 2012 Oct; 29(7):821-39. PubMed ID: 23053740
[TBL] [Abstract][Full Text] [Related]
60. [Application of positron emission tomography in diagnosis of liver metastases from colorectal cancer].
Fu CG; Wang HT; Kong LS; Cui B
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):17-9. PubMed ID: 16148990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
